Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFoxtons Regulatory News (FOXT)

Share Price Information for Foxtons (FOXT)

Share Price is delayed by 15 minutes
Get Live Data
45.10    -0.70 (-1.53%)
Bid:
45.10
Ask:
46.35
Spread: 1.25 (2.772%)
Market Cap: £133.36m
FOXT Live PriceLast checked at - London Stock Exchange

Intraday Foxtons Share Chart

Foxtons Share Buyback Programme Announcement

8 Apr 2025 07:00

RNS Number : 0114E
Foxtons Group PLC
08 April 2025
 

FOXTONS GROUP PLC

(the "Company" or "Foxtons")

 

Up to £3 million share buyback programme

Tuesday 8 April 2025

 

Foxtons Group plc (LSE: FOXT) announces the commencement of a share buyback programme of up to £3 million. The Board continuously reviews shareholder return opportunities, and specifically the use of share buybacks, considering factors such as earnings per share accretion, borrowing capacity and leverage.

After considering the Company's prevailing share price, balance sheet position, forecast liquidity and timing of further lettings portfolio acquisitions, the Board has decided to return capital to shareholders through the buyback programme announced today.

The proposed share buyback will be funded using the Group's existing cash balances and revolving credit facility. Foxtons will continue to pursue lettings portfolio acquisition opportunities within its capital allocation framework.

The Company has appointed Singer Capital Markets ("Singer") to manage the share buyback programme to repurchase Ordinary Shares on its behalf, up to a maximum aggregate consideration of £3 million and subject to certain other set parameters. All shares acquired under this buyback programme will be cancelled.

The buyback programme is in accordance with Foxtons' general authority to purchase Ordinary Shares granted by its shareholders at the Annual General Meeting held on 7 May 2024. The share buyback programme will also be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019).

Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The maximum price paid per Ordinary Share will be no more than the higher of (i) 105 per cent of the average middle market closing prices of the Ordinary Shares for the five business days preceding any Ordinary Shares being purchased and (ii) the higher of the price of the last independent trade and the highest independent bid for Ordinary Shares on the trading venue where the purchase is carried out.

Due to the limited liquidity in the issued Ordinary Shares, a buyback of Ordinary Shares pursuant to the buyback programme on any given trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the London Stock Exchange and may exceed 25 per cent of the average daily trading volume and, accordingly, the Company may not benefit from the exemption contained in Article 5(1) of Regulation (EU) No. 596/2014.

The Company will make further regulatory announcements to shareholders in respect of purchases of Ordinary Shares by the Company as they occur.

The Company confirms that it currently has no other unpublished price sensitive information other than the information that has been communicated within this announcement.

 

 

For further information, please contact:

Foxtons Group plc

 

investor@foxtonsgroup.co.uk

 

Chris Hough, Chief Financial Officer

Muhammad Patel, Investor Relations

 

+44 20 7893 6261

 

Cardew Group

Will Baldwin-Charles / Olivia Rosser

 

 Foxtons@cardewgroup.com

+44 7834 524833 / +44 7552 864 250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKOBKDBKBDQK
Date   Source Headline
1st Jun 202612:44 pmRNSTotal Voting Rights
26th May 20269:23 amRNSDirectorate change
22nd May 20265:10 pmRNSDirector/PDMR Shareholding
7th May 20264:27 pmRNSResult of AGM
1st May 202612:04 pmRNSTotal Voting Rights
23rd Apr 20267:00 amRNSQ1 2026 Trading Update
13th Apr 20265:05 pmRNSTransaction in Own Shares
10th Apr 20266:15 pmRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20263:44 pmRNSTransaction in Own Shares
1st Apr 202612:18 pmRNSDirector/PDMR Shareholding
1st Apr 202611:33 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSNotice of AGM and Annual Report and Accounts
31st Mar 20261:46 pmRNSTransaction in Own Shares
30th Mar 20265:19 pmRNSTransaction in Own Shares
27th Mar 20265:26 pmRNSTransaction in Own Shares
26th Mar 20265:43 pmRNSTransaction in Own Shares
25th Mar 20269:23 amRNSTransaction in Own Shares
20th Mar 20264:44 pmRNSTransaction in Own Shares
20th Mar 202611:08 amRNSHolding(s) in Company
19th Mar 20263:38 pmRNSTransaction in Own Shares
18th Mar 20263:26 pmRNSTransaction in Own Shares
17th Mar 20265:37 pmRNSTransaction in Own Shares
16th Mar 20266:12 pmRNSTransaction in Own Shares
13th Mar 20265:14 pmRNSTransaction in Own Shares
12th Mar 20265:54 pmRNSTransaction in Own Shares
11th Mar 20265:33 pmRNSTransaction in Own Shares
10th Mar 20263:07 pmRNSTransaction in Own Shares
10th Mar 20263:07 pmRNSTransaction in Own Shares
6th Mar 20265:55 pmRNSTransaction in Own Shares
6th Mar 20264:12 pmRNSDirector/PDMR Shareholding
5th Mar 20265:48 pmRNSTransaction in Own Shares
5th Mar 20267:00 amRNSFull Year Results For Year Ended 31 December 2025
20th Feb 202611:32 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSBoard Change
2nd Feb 20262:22 pmRNSTotal Voting Rights
27th Jan 20266:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSAcquisition of Birmingham-based FleetMilne
15th Jan 20267:00 amRNSUnaudited Year End Trading Update and Acquisition
14th Jan 20265:28 pmRNSTransaction in Own Shares
13th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
8th Jan 20263:04 pmRNSHolding(s) in Company
2nd Jan 202611:59 amRNSTotal Voting Rights
22nd Dec 20255:40 pmRNSTransaction in Own Shares
22nd Dec 20255:40 pmRNSTransaction in Own Shares
17th Dec 20255:24 pmRNSTransaction in Own Shares
2nd Dec 20255:49 pmRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
1st Dec 202510:38 amRNSTotal Voting Rights
26th Nov 20256:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.